Compared to Estimates, Elanco Animal Health (ELAN) Q1 Earnings: A Look at Key Metrics

Elanco Animal Health Incorporated (ELAN) reported $1.19 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 1%. EPS of $0.37 for the same period compares to $0.34 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.17 billion, representing a surprise of +2.17%. The company delivered an EPS surprise of +19.35%, with the consensus EPS estimate being $0.31.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Elanco Animal Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Total Pet Health: $635 million versus $649.71 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -0.6% change. Revenue- Total Contract Manufacturing: $12 million versus $9.95 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +20% change. Revenue- Total Farm Animal: $546 million versus $510.15 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -1.8% change. View all Key Company Metrics for Elanco Animal Health here>>>Shares of Elanco Animal Health have returned +14.2% over the past month versus the Zacks S&P 500 composite's +10.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Elanco Animal Health Incorporated (ELAN): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks